Literature DB >> 19347871

Stem cell exhaustion and leukemogenesis.

Bindya Jacob1, Motomi Osato.   

Abstract

Cancer is the result of a combination of genetic alterations, which aid transformation of cells. However, oncogenic alterations also simultaneously induce some detrimental effects on the cells such as apoptosis, senescence, and differentiation. Such negative effects caused by certain oncogenic events are overcome by other cooperating genetic hits. We propose stem cell exhaustion as a novel detrimental effect that is caused by a wide variety of oncogenic alterations. Interestingly, in most cases, the stem cell exhaustion due to oncogenic alterations is preceded by an abnormal expansion of stem/progenitor cells. This preceding stem/progenitor cell expansion may be a key feature that still promotes cancer development, along with cooperating hits that rescue stem cell exhaustion. This review summarizes current knowledge about hematopoietic stem cell exhaustion and the mechanisms to overcome stem cell exhaustion in cancer development. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19347871     DOI: 10.1002/jcb.22150

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

Review 1.  The aryl hydrocarbon receptor: regulation of hematopoiesis and involvement in the progression of blood diseases.

Authors:  Fanny L Casado; Kameshwar P Singh; Thomas A Gasiewicz
Journal:  Blood Cells Mol Dis       Date:  2010-02-19       Impact factor: 3.039

Review 2.  Stem Cell Quiescence: Dynamism, Restraint, and Cellular Idling.

Authors:  Cindy T J van Velthoven; Thomas A Rando
Journal:  Cell Stem Cell       Date:  2019-02-07       Impact factor: 24.633

3.  RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element.

Authors:  Elena Levantini; Sanghoon Lee; Hanna S Radomska; Christopher J Hetherington; Meritxell Alberich-Jorda; Giovanni Amabile; Pu Zhang; David A Gonzalez; Junyan Zhang; Daniela S Basseres; Nicola K Wilson; Steffen Koschmieder; Gang Huang; Dong-Er Zhang; Alexander K Ebralidze; Constanze Bonifer; Yutaka Okuno; Bertie Gottgens; Daniel G Tenen
Journal:  EMBO J       Date:  2011-08-26       Impact factor: 11.598

Review 4.  The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: implications for benzene-induced hematopoietic toxicity.

Authors:  Thomas A Gasiewicz; Kameshwar P Singh; Fanny L Casado
Journal:  Chem Biol Interact       Date:  2009-11-05       Impact factor: 5.192

Review 5.  The Ah receptor in stem cell cycling, regulation, and quiescence.

Authors:  Thomas A Gasiewicz; Kameshwar P Singh; J Allen Bennett
Journal:  Ann N Y Acad Sci       Date:  2014-02-03       Impact factor: 5.691

Review 6.  The Hematopoietic Stem/Progenitor Cell Response to Hemorrhage, Injury, and Sepsis: A Review of Pathophysiology.

Authors:  Lauren S Kelly; Dijoia B Darden; Brittany P Fenner; Philip A Efron; Alicia M Mohr
Journal:  Shock       Date:  2021-07-01       Impact factor: 3.533

7.  PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL.

Authors:  Brandi L Carofino; Bernard Ayanga; Lauren J Tracey; Travis Brooke-Bisschop; Monica J Justice
Journal:  Biol Open       Date:  2016-05-15       Impact factor: 2.422

8.  Enhanced Dentate Neurogenesis after Brain Injury Undermines Long-Term Neurogenic Potential and Promotes Seizure Susceptibility.

Authors:  Eric J Neuberger; Bogumila Swietek; Lucas Corrubia; Anagha Prasanna; Vijayalakshmi Santhakumar
Journal:  Stem Cell Reports       Date:  2017-08-17       Impact factor: 7.765

9.  Cell Kinetics in the Adult Neurogenic Niche and Impact of Diet-Induced Accelerated Aging.

Authors:  Alexander J Stankiewicz; Farzad Mortazavi; Peter V Kharchenko; Erin M McGowan; Vasili Kharchenko; Irina V Zhdanova
Journal:  J Neurosci       Date:  2019-02-08       Impact factor: 6.167

Review 10.  What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer.

Authors:  Julie-Aurore Losman; William G Kaelin
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 12.890

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.